
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD)’s Pimavanserin is capable of realizing $1 billion in sales
Boston, MA 27/06/2013 (wallstreetpr) – ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) traded at $17.82 in the previous trading session after going upwards by $1.02 (or 6.07%). The













